Associated Papers
Convergent and Divergent Mechanisms of Epileptogenesis in mTORopathies.
Nguyen LH et al.
Frontiers in Neuroanatomy, 2021
Pathological mTOR mutations impact cortical development.
Tarkowski B et al.
Human Molecular Genetics, 2019
ULK1 O-GlcNAcylation Is Crucial for Activating VPS34 via ATG14L during Autophagy Initiation.
Pyo KE et al.
Cell Reports, 2018
Evidence Supporting a Lymphatic Endothelium Origin for Angiomyolipoma, a TSC2(-) Tumor Related to Lymphangioleiomyomatosis.
Yue M et al.
The American Journal of Pathology, 2016
Unrestrained mammalian target of rapamycin complexes 1 and 2 increase expression of phosphatase and tensin homolog deleted on chromosome 10 to regulate phosphorylation of Akt kinase.
Das F et al.
The Journal of Biological Chemistry, 2012
Mammalian TOR signaling to the AGC kinases.
Su B et al.
Critical Reviews in Biochemistry and Molecular Biology, 2011
Activating mutations of TOR (target of rapamycin).
Hardt M et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms, 2011
Activating mutations in TOR are in similar structures as oncogenic mutations in PI3KCalpha.
Sturgill TW et al.
Acs Chemical Biology, 2009
Isolation of hyperactive mutants of mammalian target of rapamycin.
Ohne Y et al.
The Journal of Biological Chemistry, 2008
Select a paper to view details